Answers are grounded in this paper and cite their sources.
Cancer remains one of the most formidable challenges in modern medicine, with conventional therapeutic modalities increasingly constrained by dose-limiting toxicities, systemic side effects, and the relentless emergence of multidrug resistance. Antimicrobial peptides (AMPs) derived from aquatic organisms—encompassing marine invertebrates, fish, amphibians inhabiting freshwater and brackish ecosystems, crustaceans, mollusks, and marine microorganisms—have emerged as a structurally diverse and mechanistically distinctive class of bioactive molecules with compelling anticancer potential. Unlike classical chemotherapeutics that predominantly target intracellular DNA replication machinery, aquatic AMPs exert their cytotoxic effects through membrane-disruptive mechanisms, receptor-mediated apoptotic cascades, immunomodulatory signaling, and selective mitochondrial targeting, thereby circumventing conventional resistance pathways. This systematic review, conducted in accordance with PRISMA guidelines, comprehensively evaluates the anticancer properties of aquatic-derived AMPs and their engineered analogues, with particular emphasis on strategic chemical and structural modification strategies that enhance their therapeutic index, proteolytic stability, selectivity, and bioavailability. We delineate the molecular mechanisms by which these peptides discriminate between malignant and healthy cells, explore structure-activity relationships (SARs) across major peptide families, and critically assess modification methodologies including D-amino acid substitution, cyclization, PEGylation, lipidation, stapling, glycosylation, nanoparticle conjugation, and hybrid peptide engineering. Emerging evidence from in vitro , in vivo , and early clinical studies is synthesized to provide a translational roadmap for the development of next-generation aquatic AMP-based oncotherapeutics. Key challenges including off-target toxicity, pharmacokinetic limitations, and scalable synthesis are discussed, alongside prospective strategies to overcome these barriers. This review underscores the transformative potential of aquatic biodiversity as an underexplored reservoir of anticancer peptide scaffolds.
No takes yet. Share an insight, caveat, or question.
Wekalao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: